A. F. Verbovoy

Obesity is the basis of metabolic syndrome

A. F. Verbovoy, N. I. Verbovaya · Obesity and metabolism · 2021 · 27 citations · Full text

Life Sciences, Endocrinology, Physiology +17

A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus

Marina V. Shestakova, John Wilding, Wim Wilpshaar et al. · Diabetes Research and Clinical Practice · 2018 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Insulin resistance in therapeutic clinic

A. F. Verbovoy · Obesity and metabolism · 2017 · 21 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)

T. V. Kharitonova, Yury G Shvarts, A. F. Verbovoy et al. · BMJ Open Diabetes Research & Care · 2022 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Obesity and cardiovascular system

A. F. Verbovoy · Clinical Medicine (Russian Journal) · 2017 · 16 citations · Full text

Public Health, Cardiology, Population Health +11